Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth-0.19%

4Groww
0.00%
1 Year Return
Equity
Sectoral-Pharma
4.0 star
All

Fund Details

Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth

RiskHigh
Min SIP Amount₹500
Expense Ratio0.91%
NAV10.63 (09 Dec 2019)
Fund Started10 Jul 2019
Fund Size171 Cr

Returns

1Y
3Y*
5Y*
Since inception*
Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
NA
NA
NA
6.3%
Category Average
-10.4%
-4.3%
1.5%
-
Rank within category
NA
NA
NA
-
*All returns are annualized.
SIP
Lumpsum
I want to invest per month5,000
    Estimated Value
    as per Historical Returns
    0
    with 2.8% annual returns

    Comparison

    Data not available
    Pros
    Found nothing so far.
    Cons
    Found nothing so far.

    Top Holdings

    NameSectorInstrument% Assets
    Sun Pharmaceutical Inds. Ltd.HealthcareEquity11.1%
    Cipla Ltd.HealthcareEquity9.2%
    Lupin Ltd.HealthcareEquity7.9%
    Alkem Laboratories Ltd.HealthcareEquity5.8%
    Divi's Laboratories Ltd.HealthcareEquity5.4%
    Atul Ltd.ChemicalsEquity5.4%
    Apollo Hospitals Enterprise Ltd.HealthcareEquity4.8%
    Torrent Pharmaceuticals Ltd.HealthcareEquity4.7%
    Dr. Reddy's Laboratories Ltd.HealthcareEquity4.5%
    Aurobindo Pharma Ltd.HealthcareEquity4.2%
    See All

    Fund Managers

    addDhaval Shah
    Education
    Mr.Shah has done B.Com. from University of Mumbai & MBA from Somaiya Institute of Management Studies & Research. He also holds CFA designation.
    Experience
    Prior to joining Aditya Birla Sunlife Mutual Fund he has worked with HDFC Mutual Fund, Reliance Mutual Fund, Morgan Stanley.
    Funds Managed

    Other Details

    Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is a Equity Mutual Fund Scheme launched by Aditya Birla Sun Life Mutual Fund. This scheme was introduced to investors on 10 Jul 2019. Dhaval Shah is the Current Fund Manager of Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth.The fund currently has an Asset Under Management(AUM) of ₹171 Cr and the Latest NAV as of 09 Dec 2019 is ₹10.63.

    The Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth is rated High risk. Minimum SIP Investment is 500. Minimum Lumpsum Investment is 1000. Exit load of 0.5% if redeemed within 90 days..

    Investment Objective

    The scheme seeks to provides long term capital appreciation by investing in equity/equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.

    Tax Implications

    Scheme Information Document(SID)

    ₹1000
    Min for First Investment
    ₹1000
    Min for Second Investment
    Exit load of 0.5% if redeemed within 90 days.
    Exit Load

    Compare Funds

    Aditya Birla Sun Life Pharma & Healthcare Fund Direct Growth
    VS
    search

    About Aditya Birla Sun Life Mutual Fund

    Address
    One India Bulls Center - Tower 1,17th Floor - Jupiter Mills Compound,841 Senapati Bhawan, Elphinstone Road, Mumbai 400013
    Phone
    022-43568000/ 1800-270-7000/ 1800-22-7000
    Launch Date
    22 Dec 1994
    E-mail
    NA
    Website
    NA
    Aditya Birla Sun Life Mutual Fund
    Asset Management Company
    Custodian
    Citibank NA
    Registrar & Transfer Agent
    Cams
    Address
    7th Floor, Tower II, Rayala Towers, 158, Anna Salai,
    Invest Now
    Enter investment amount
    + ₹1,000
    + ₹5,000
    + ₹10,000
    ONE TIME
    MONTHLY SIP
    Similar Funds
    Data not available
    ⓒ 2019 Billionbrains Garage Ventures Private Limited